TY - JOUR
T1 - Differences in plasma fatty acid composition related to chronic pancreatitis
T2 - A pilot study
AU - Gumpper-Fedus, Kristyn
AU - Crowe, Olivia
AU - Hart, Phil A.
AU - Pita-Grisanti, Valentina
AU - Velez-Bonet, Ericka
AU - Belury, Martha A.
AU - L. Ramsey, Mitchell
AU - Cole, Rachel M.
AU - Badi, Niharika
AU - Culp, Stacey
AU - Hinton, Alice
AU - F. Lara, Luis
AU - Krishna, Somashekar G.
AU - Conwell, Darwin L.
AU - Cruz-Monserrate, Zobeida
N1 - Publisher Copyright:
© Wolters Kluwer Health, Inc. All rights reserved.
PY - 2024/5/1
Y1 - 2024/5/1
N2 - Objectives Chronic pancreatitis (CP) is an inflammatory disease affecting the absorption of fat-soluble nutrients. Signaling in pancreatic cells that lead to inflammation may be influenced by fatty acids (FAs) through diet and de novo lipogenesis. Here, we investigated the relationship between plasma FA composition in CP with heterogeneity of etiology and complications of CP. Materials and Methods Blood and clinical parameters were collected from subjects with CP (n = 47) and controls (n = 22). Plasma was analyzed for FA composition using gas chromatography and compared between controls and CP and within CP. Results Palmitic acid increased, and linoleic acid decreased in CP compared with controls. Correlations between age or body mass index and FAs are altered in CP compared with controls. Diabetes, pancreatic calcifications, and substance usage, but not exocrine pancreatic dysfunction, were associated with differences in oleic acid and linoleic acid relative abundance in CP. De novo lipogenesis index was increased in the plasma of subjects with CP compared with controls and in calcific CP compared with noncalcific CP. Conclusions Fatty acids that are markers of de novo lipogenesis and linoleic acid are dysregulated in CP depending on the etiology or complication. These results enhance our understanding of CP and highlight potential pathways targeting FAs for treating CP.
AB - Objectives Chronic pancreatitis (CP) is an inflammatory disease affecting the absorption of fat-soluble nutrients. Signaling in pancreatic cells that lead to inflammation may be influenced by fatty acids (FAs) through diet and de novo lipogenesis. Here, we investigated the relationship between plasma FA composition in CP with heterogeneity of etiology and complications of CP. Materials and Methods Blood and clinical parameters were collected from subjects with CP (n = 47) and controls (n = 22). Plasma was analyzed for FA composition using gas chromatography and compared between controls and CP and within CP. Results Palmitic acid increased, and linoleic acid decreased in CP compared with controls. Correlations between age or body mass index and FAs are altered in CP compared with controls. Diabetes, pancreatic calcifications, and substance usage, but not exocrine pancreatic dysfunction, were associated with differences in oleic acid and linoleic acid relative abundance in CP. De novo lipogenesis index was increased in the plasma of subjects with CP compared with controls and in calcific CP compared with noncalcific CP. Conclusions Fatty acids that are markers of de novo lipogenesis and linoleic acid are dysregulated in CP depending on the etiology or complication. These results enhance our understanding of CP and highlight potential pathways targeting FAs for treating CP.
KW - Alcohol use
KW - Diabetes
KW - Linoleic acid
KW - Palmitic acid
KW - Pancreatitis
KW - Smoking
UR - http://www.scopus.com/inward/record.url?scp=85193086696&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85193086696&partnerID=8YFLogxK
U2 - 10.1097/MPA.0000000000002318
DO - 10.1097/MPA.0000000000002318
M3 - Article
C2 - 38530954
AN - SCOPUS:85193086696
SN - 0885-3177
VL - 53
SP - E416-E423
JO - Pancreas
JF - Pancreas
IS - 5
ER -